Archives
Meeting Archives
No meeting archives available.
Video Sessions
April 25 2017
The Changing Landscape of Von Willebrand Disease Diagnosis
Presenter: Dr. Veronica Flood
Summary:
- Improved understanding of laboratory tests available for VWD diagnosis
- Improved understanding of the classification of VWD and implications for treatment
April 18 2017
Contraception and Thrombosis in Adolescents
Presenter: Dr. Shannon Bates
Summary:
- Review the risks of thrombosis with various forms of hormonal contraception
- Understand the thromboembolic risks of hormonal contraception in adolescents with a hereditary thrombophilia and/or family history of venous thromboembolism
January 31 2017
Reversal of DOACs: State of the Art
Presenter: Dr. Mark Crowther
Summary:
- Review current evidence for DOAC reversal
- Discuss strategies in light of lack of widespread availability of Xa inhibitors
- Present current best evidence for reversal
November 15 2016
Are Rare Inherited Bleeding Disorders the Holy Grail of Bleeding Disorders?
Presenter: Dr. Suchitra S. Acharya
Summary:
- Identify the phenotype, including clinical manifestations, for rare bleeding disorders (RBDs)
- Describe the appropriate evaluation for a suspected RBD and discuss available coagulation factor replacement therapy and hemostatic agents for these rare disorders
- Recognize unmet needs for RBDs and their families
April 5 2016
Congenital Fibrinogen Deficiencies
Presenters: Mr. Marilyn Manco-Johnson
Summary:
- now basic structure and function of the normal fibrinogen molecule and genetic/molecular mechanisms of deficiency states
- Evaluate fibrinogen functions in deficiency states using global assays to model hemostasis
- Understand the mechanisms by which afibrinogenemia can cause both bleeding and clotting symptoms
- Be familiar with use and dosing of fibrinogen replacement concentrates
January 12 2016
Optimizing Warfarin Management in Canada
Presenters: Dr. Murray Trusler
Summary:
- To revisit the standard of care for warfarin management in Canada
- To share the experience of a Canadian paediatric centre of anticoagulation excellence
- To provide a closer look at the DOAC clinical trial results
November 10 2015
ITP: An Old Disease with New Developments
Presenter: Dr. Cindy Neunert
Summary:
- Provide an overview of the pathogenesis of ITP
- Outline a rationale for the current management options in pediatric ITP
- Highlight national and international collaborative research efforts in pediatric ITP
May 19 2015
EmPoWARed: Warfarin Self Management in Pediatrics
Presenters: Ms. Mary Bauman and Dr. Aisha Bruce
Summary:
- To describe the current landscape of warfarin outpatient management in pediatrics
- To review the current models of care
- To describe pediatric patient self-management of warfarin – EmPoWARed Study
- To describe quality of life and qualitative data from the EmPoWARed study
May 26 2015
TPO Agents in Children
Dr. James Bussel
Summary:
- Recognize the role of TPO agents in chronic ITP
- Appreciate studies of efficacy in children with ITP
- Be aware of the toxicity of TPO agents
March 10 2015
Coagulation in Children with Liver Disease
Dr. Simon Ling and Dr. Maria Magnusson
Summary:
- To describe the bleeding and thrombotic complications that occur in chronic severe liver disease and approaches to their prevention and treatment
- To understand the effects of chronic liver disease on the balance between pro-coagulant and anti-coagulant factors, and the limitations of laboratory tests to measure this balance.
December 16 2014
Overview of Pediatric Endovascular Thrombosis Interventions
Dr. Michael Temple and Dr. Suzan Williams
Summary:
- To describe current approaches to endovascular thrombosis intervention
- To identify patients who may benefit from endovascular thrombosis intervention
- To describe indications for inferior vena cava filters in children
- To be aware of the limitations of inferior vena cava filter use in children
January 2014
Global Coagulation Testing
Dr. Georges E. Rivard
Summary:
- Identify and explain the relative merit of two global hemostatic technologies: TEG/ROTEM and Thrombin Generation
- Identify and recommed the Global hemostat assays for the investigation of bleeding disorders
- Identify and recommend Global hemostatic assays for the management of congenital and acquired bleeding disorders